Search Results 1141-1150 of 19889 for Receptor

  1. A Study To Evaluate Patient And Provider Choices On Incorporating Chemoprevention Into Care - Mayo Clinic

    Patients must not have prior or current use of selective estrogen receptor modulators (SERMs) or aromatase inhibitors (AIs). NOTE: The following are ...

  2. Blood pressure: Does it have a daily pattern? - Mayo Clinic

    Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin ...

  3. A Study Of BH-30643 In Subjects With Locally Advanced Or Metastatic NSCLC Harboring EGFR And/or HER2 Mutations - Mayo Clinic

    ... receptor (EGFR) and/or human epidermal growth factor receptor (HER2) mutations. The study drug, BH-30643 capsules, will be self-administered by mouth twice ...

  4. Publications - Gerardo Colon-Otero, M.D. - Mayo Clinic

    ... Receptor-Positive, HER2-Positive Breast Cancer. J Natl Compr Canc Netw. 2024 Aug 26; 22 (7):463-468. View PubMed; Díaz-Cortés H, Hedges MS, Pacheco-Spann LM ...

  5. Paraganglioma - Diagnosis and treatment - Mayo Clinic

    Treatment · Treatments to control hormones made by the tumor · Surgery · Radiation therapy · Ablation therapy · Chemotherapy · Targeted therapy · Peptide receptor ...

  6. Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    Developing chimeric antigen receptor (CAR)‑macrophage and CAR‑T cell therapies to function effectively within hostile metastatic niches. Examining how ...

  7. Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    ... receptor antagonists or proton pump inhibitors; Known active infection with human immunodeficiency virus (HIV), hepatitis B virus, or hepatitis C; Autologous ...

  8. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    ... Receptor 2 (HER-2) positive tumor - Known untreated, symptomatic, or actively progressing central nervous system (brain) metastases. Participants with ...

  9. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

    ... receptor 2 (FGFR2). Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. A Study of ABC294640 ...

  10. Phase 3 Study of Vimseltinib for Tenosynovial Giant Cell Tumor - Mayo Clinic

    Previous use of systemic therapy targeting colony stimulating factor 1 (CSF1) or CSFR1 receptor (CSF1R); previous therapy with imatinib and nilotinib is allowed ...